Figure 1.
Adverse events of lenvatinib treatment. (A) Incidence rate, dose reduction rate, and treatment discontinuation rate. (B) Profile of adverse events. AE: adverse event.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.